Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Interview: Enhancing Clinical Trials with CliniPilot and Clear to Clinic Programme

In this exclusive interview, Dr Carolina Canapè and Roger Lüscher talk with ONdrugDelivery’s Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors …

Closing the loop: Designing the future of sustainable drug delivery devices

As pharma moves toward net zero, device sustainability is under the spotlight. In our latest blog, Thuysi Dao outlines a two-pronged approach that combines sustainable device design with take-back and recycling possibilities – showcased through the …

Divergent design philosophies in the wearable injector segment

Wearable injectors come in many shapes and concepts. Our latest blog explores this diversity, and shows how YpsoDose stands out with consistent injection and minimal residual volume in large-volume self-injection.

Patient-centricity at the heart of innovation

Discover the patient-driven design behind YpsoDose, our wearable patch injector for large-volume biologics. Learn how human factors shaped its intuitive, comfortable, and reliable use—simplifying self-injection for patients at home.

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.

Sustainable GLP-1 drug delivery

GLP-1 therapies are entering a high-growth phase, driving demand for scalable, sustainable delivery solutions. As formulations evolve, device usability, and environmental impact becomes a key industry challenge.

Connected selfcare: setting a new standard

Whitepaper – How to establish clear measurable outcome metrics that align technology with therapeutic goals and couple robust data generation strategies with holistic patient experience and treatment efficacy.

Advancing large-volume subcutaneous drug delivery

What are the latest trends in large-volume drug delivery? A recent study explores key developments, while Ypsomed’s innovative injection platforms address the challenges of large volumes and high viscosities with patient-friendly solutions.

CE-certified reusable pens: Immediate certification for market access

Discover how Ypsomed’s CE-certified reusable pens, ServoPen and YpsoPen, streamline market access. Our innovative platform model simplifies compliance, accelerates product availability, and provides comprehensive support to pharmaceutical partners at …

Notice

Welcome to the Ypsomed Blog